Background
Introduction
Skeletal muscle alteration is a recognised extra-pulmonary consequence of Chronic Obstructive Pulmonary Disease (COPD) with particular involvement of the larger muscles of locomotion (1;2) . Although the precise causes and mechanisms are still being elucidated, deconditioning from inactivity, systemic inflammation, oxidative stress, hypoxaemia and steroid use have all been implicated (all of which worsen with increasing disease severity) (1;3). Reduced quadriceps muscle mass and strength in COPD (4) have been associated with a higher mortality (5;6) and morbidity, as well as increased hospital admissions (7) .
There is also considerable evidence that the oxidative capacity of the skeletal muscle is reduced in COPD with preferential reduction in the type I fibre cross sectional area of the quadriceps muscle and a reduction in oxidative enzyme concentration, mitochondrial density and capillary density (8;9) . Collectively, these changes likely contribute to exercise and activity intolerance (10) (11) (12) . These adaptations are associated with a loss of the aerobic profile of the muscle. This is exemplified during cycling exercise where the muscle energy requirements are unable to be met with a resultant decline in Phosphocreatine and Adenosine Trinucleotide Phosphate (ATP) at very low absolute power (12) . Whole body exercise tests such as incremental cycling or treadmill walking do not isolate the contribution of the peripheral muscles to the impaired aerobic capacity since the latter can also be attributed to ventilatory constraints (13) and redistribution of cardiac output to the respiratory muscles (14) . Therefore, tasks that specifically target localised muscle endurance are needed to determine the functional consequences of cellular changes observed in the limb muscles of individuals with COPD.
Muscle endurance and fatigue of the quadriceps (knee extensor muscle group) have been measured using a variety of techniques in individuals with COPD. Muscle endurance has been defined as the ability of muscle to perform repeated work and resist fatigue whereas muscle fatigue has been defined as a decline in the force generating capacity of a muscle (15) . Muscle fatigue occurs as a result of impairment at one or more points along the pathway for muscle contraction ( Figure 1 ). As different tasks target different aspects of this pathway, the type of measurement protocol chosen (type, intensity, frequency and duty cycle) can have an important effect on study results (16) . Different approaches have been used to measure the two interrelated concepts of muscle endurance and fatigue in individuals with COPD with varying results (17) (18) (19) . Consequently, it is not definitively known whether quadriceps muscle endurance is reduced in COPD nor how different measurement protocols may influence the interpretation of results.
The primary aim of this study was to resolve the existing uncertainty of whether quadriceps muscle endurance is reduced in individuals with COPD compared to healthy controls and to quantify the difference. The secondary aims were to describe the methodologies reported to measure quadriceps endurance in COPD, investigate whether the type of measurement performed influenced the results, and determine whether disease severity affected the relationship between quadriceps endurance in COPD compared to healthy controls.
Methods

Study design
We performed a systematic review of studies comparing quadriceps endurance in COPD with healthy controls consistent with PRISMA guidelines (20) .
Eligibility criteria
We included studies involving individuals with COPD and any measurement of quadriceps/knee extensor endurance. Eligibility required a comparison with a healthy control group. All languages were accepted and if necessary translated to English. Grey literature searches were performed by screening the references from all relevant review articles and international guidelines (2) . 
Search strategy
Study selection
After duplicates were removed, the abstracts of all identified citations were reviewed by two assessors independently (RE and EK). The full text citation was reviewed if one of the assessors concluded it was eligible. The full text was then reviewed by RE with the final decision for inclusion taken by SM.
Data extraction
Two reviewers performed data extraction (EK and MB) which was checked and, where needed, transformed (see statistical analysis section) by a third reviewer (RE). Baseline demographics, spirometry, details of the study design, measurement properties, and results of the measurement were extracted using a standardised form. Study authors were contacted if additional data were needed.
Outcome measurements
The primary outcome measure was quadriceps endurance. The units of measurement varied depending on the type of measurement used. A priori we included any measure of muscle endurance, both sustained and intermittent contractions, isometric or isokinetic movement, as well as intensity (% Maximal Voluntary Contraction [MVC]), measured with either volitional or non-volitional tasks. In studies where both volitional and nonvolitional measurements were made, both outcomes were recorded. Studies involving exercise in which a predominant ventilatory limitation was observed were excluded. For example, studies wherein the intent of exercise was to reduce the total active muscle such as single leg cycling or high intensity knee-extensor training, but the limitation to exercise remained predominantly a ventilatory limitation rather than peripheral, were excluded. Practically, the studies excluded were those where the mean peak ventilation (VE L/min) was greater than 80% of the maximal voluntary ventilation at the end of the test in question.
A high intensity task was defined as a task involving contractions at > 50% MVC (21) .
The force-time index was used to quantify endurance time over a range of power when different versions of a similar protocol had been used. It provides a way to relate fatigue of the muscle system to the relative energy requirements, power or rate of work, of the exercise. The total energy requirements can be related to the rate of relative force accumulation, the product of the force generated and the duration of force production.
The force-time index was plotted against endurance time where the force-time index = (contraction force · maximium voluntary contraction) · duty cycle, and the duty cycle = time of the contraction / total time of the cycle.
Quality assessment
Assessment of the methodological quality of the studies was performed by two independent researchers (EK and RE) based on the relevant components of the checklist by Downs and Black (22) . Any disagreements were resolved by consensus with a third reviewer (SM).
Statistical analysis
Standardised mean differences (SMD) and their standard errors were calculated for each study. The SMD is used as a summary statistic for meta-analyses for studies which all assess the same outcome but measure it in a variety of ways. It expresses the size of the intervention effect in each study relative to the variability observed in that study, and is calculated by taking the difference in the mean outcome measure between the two groups and dividing it by the standard deviation.
Where studies reported results by sub-groups (for example, separated by gender) numbers were combined to give a single result for each study. Standard deviations were calculated if originally presented as standard error using SD = SE·√n where n represents the sample size. A random effects meta-analysis was carried out to combine results across all 21 studies. Separate meta-analyses were also carried out for non-volitional studies to explore the effects of heterogeneity between studies in terms of measurement technique and Cohen's d was calculated for effect size (23) . Meta-regression models were fitted to assess the influence of type of measurement (high vs. low intensity) and disease severity of the population studied on the relationship between quadriceps endurance between COPD and healthy controls. with COPD and n = 79 (22%) healthy controls] were excluded because of missing data, which was unavailable from the authors (24) (25) (26) (27) studies, individuals with co-morbidities that could influence quadriceps endurance were excluded: cardiovascular disease (n=18), renal (n=8), endocrine (n=14), liver (n=7), orthopaedic (n=7), neurological (n=3). Quadriceps strength was measured in all 21 studies and was significantly reduced in 16 of the studies.
Results
Identification of studies
Description of the techniques used
A number of different techniques were used to assess muscle endurance which are described in Table 1 . Five studies included non-volitional measurements and 10 of the 16 studies using volitional measurements involved high intensity tasks.
Quality assessment
A quality assessment for each study is presented in Table 2 . The quality scores tended to be low because of insufficient reporting on recruitment and retention rates, and blinding.
Of note, the study participants were not all clearly described; full spirometric data was not reported in the healthy control group in 5 studies. The primary purpose for eight studies was to compare muscle endurance in COPD and healthy controls.
Quadriceps endurance in COPD compared to healthy controls
Based on results from 21 studies, quadriceps endurance was reduced in COPD compared to healthy controls (SMD 1.16 (95% CI: 1.02 to 1.30) in favour of the healthy controls, p<0.001) shown in Figure 3 . In this meta-analysis, a positive SMD showed that the healthy individuals performed better than the patients with COPD, whilst a negative value indicated the patients with COPDperformed better. As the SMD combines outcomes that have been measured on different scales, the magnitude of the SMD cannot be interpreted further than this. There was significant heterogeneity among studies: I 2 = 93.8%, p<0.001.
Results of quadriceps endurance depending on the type of measurement made
Five studies (from the same research group) used a non-volitional approach by applying magnetic stimulation to the femoral nerve (34;37-39;42); (Table 1) There was a large range in the intensity (% MVC) and thus task duration across studies, which likely leads to different substrates and cellular pathways being utilized for energy production and muscular work. Coronell et al. used very low intensity tasks (repeated contractions of 10% MVC) (30) and showed the largest standardised mean difference between groups. This type of low intensity task is more "aerobic" in nature as it allows for adequate blood flow to and from the muscle (47), but it can also be limited by changes in central activation or peripheral factors, distal to the neuromuscular junction (48) . As such, the expected curvilinear relationship between the force-time index and endurance time ( Figure 5 ) was observed in healthy controls but not in COPD (30-32;35;40) ; this was mainly affected by two studies using very low intensity protocols.
Therefore, it is speculated that both impaired aerobic capacity of the quadriceps muscle and central factors contribute to reduced muscle endurance in COPD.
Some of the studies involved a very high intensity task (less than one minute in duration) (51) . Overall, the reduction in muscle endurance compared with controls, was noted with both low and high intensity tasks.
Clinical implications
Exercise training is a major therapeutic strategy for individuals with COPD and currently a combination of aerobic (either cycling or walking) and strength training is recommended (52) . The results of this synthesis show that muscle endurance in COPD is reduced highlighting the need for the inclusion of muscle-specific training. Partitioned training such as one-legged cycling has been shown to be more effective in improving peak oxygen uptake than two-legged cycling in COPD, (53;54) and a recent paper reported restored oxidative enzyme activity of the quadriceps using high intensity knee extensor training (one leg at a time) in COPD (55) . There has been interest into the pharmacological manipulation of the oxidative capacity of skeletal muscle in animal models and our review highlights the potential relevance for individuals with COPD (56;57).
Limitations
Four studies (less than 20%) had to be excluded as we were unable to obtain the necessary data from the original authors, but there were no differences in the demographics of the study sample between the excluded studies and those included in the meta-analysis. We included all types of muscle endurance and fatigue measures into the meta-analysis, which led to large heterogeneity (I 2 = 93.8%). However, the main relationship was unchanged in the meta-analysis restricted to the non-volitional studies,
where the heterogeneity was substantially reduced. While the reduction in muscle endurance was independent of measured airflow obstruction, our results may be subject to population bias given the lack of individuals with milder reductions in airflow obstruction. This review pertains to the large quadriceps muscle group of the leg only and the results should not be extrapolated to other muscle groups which may have different usage and fatigue properties.
The low quality assessment results of the included studies are also a limitation of the review, but likely did not affect our findings given the large number of studies that were included. Nonetheless, the quality results highlight the need for improved adherence to reporting standards for future work.
Summary
In a large number of individuals with COPD, we have shown that quadriceps endurance is reduced compared to healthy controls independent of type of task and measurement technique. In addition to the cellular changes that have been observed in muscle oxidative capacity, neuromotor changes that may contribute to the early onset of muscle fatigue should be further examined in this population. Our findings have implications for the development of pharmacological and non-pharmacological therapies targeted at improving skeletal muscle endurance.
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